Rapid Dose Therapeutics Corp. (RDTCF) Research

Rapid Dose Therapeutics Corp., a life sciences enterprise based in Burlington, Canada, specializes in cutting-edge drug delivery systems aimed at enhancing health and well-being for individuals across Canada. Their core offering is the QuickStrip/PharmaStrip, an innovative oral, fast-dissolving film designed to swiftly introduce active compounds—such as pharmaceuticals, emulsified oils, and over-the-counter remedies—directly into the bloodstream. The product line includes targeted solutions like QuickStrip energy, infused with caffeine; QuickStrip B12, providing vitamin B12; and QuickStrip sleep, which delivers melatonin. Furthermore, the company provides bespoke services encompassing product innovation, manufacturing, and strategic consultation to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing sectors. Rapid Dose Therapeutics also maintains a significant research partnership with McMaster University, jointly developing advanced biopolymer compositions for optimized thin-film drug delivery and pioneering an orally administered COVID-19 vaccine candidate.

Market snapshot

Symbol
RDTCF
Price
$0.01
Day change
0.00%
Market cap
$10.6M
P/E ratio
-2.41x
52-week range
0.006-0.15
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • American Hemp Ventures, Inc. (AMHV)
  • Ceapro Inc. (CRPOF)
  • Eiger BioPharmaceuticals, Inc. (EIGRQ)
  • Living Cell Technologies Limited (LVCLY)
  • Nurosene Health Inc. (MNNDF)
  • Noxopharm Limited (NOXOF)
  • Simply Better Brands Corp. (PKANF)
  • Poxel S.A. (PXXLF)

Open Rapid Dose Therapeutics Corp. (RDTCF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.